Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Allogene Therapeutics Inc

Allogene Therapeutics Inc

ALLO · NASDAQ
ALLO · NASDAQ
1.18
USD0.033.06%

Latest News

    CoinOtag

    Binance Wallet’s ALLO (RWA) TGE Oversubscribed by 143.77 Times: A New Milestone in Crypto Investments

      CoinOtag

      Unlock ALLO (RWA) TGE Participation with Binance Alpha Points: Join the Event on May 22, 2025!

        CoinOtag

        Binance Wallet to Launch ALLO (RWA) TGE: Subscription Opens May 22, 2025

          @DeItaone
          DeItaone

          Coverage Initiated $ALLO $ALNY $ARWR $BEAM $BMRN $CRSP $IONS $NTLA $VRTX $VTYX https://t.co/HsvywOztkC https://t.co/im5wWXPsjd

            @Benzinga
            Benzinga

            $ARKG Bought - $ALLO $NTLA $VERV Sold - $CLLS $PFE $REGN https://t.co/cYbwjQ5WNr

            Analysts Recommendations

            Bullish

            Buy

            Strong Buy

            Buy

            Hold

            Sell

            Strong Sell

            Day Range

            1.11USD
            1.23USD

            52 Week Range

            0.86USD
            3.78USD

            Market Cap

            258.1MUSD

            lock-imagelock-image

            Get Full Access with Profit PRO

            See which Billionaires own this investment

            About

            General Information

            Type

            Common Stock

            Exchange

            NASDAQ

            Currency Code

            USD

            Currency Name

            US Dollar

            Country Name

            USA

            Country ISO

            US

            ISIN

            US0197701065

            CUSIP

            019770106

            Sector

            Healthcare

            Industry

            Biotechnology

            Fiscal Year End

            December

            IPO date

            -

            Updated At

            -

            Highlights

            PE Ratio

            -

            PEG Ratio

            -

            Book Value

            1.76

            Dividend Share

            -

            Dividend Yield

            -

            Earnings Share

            -1.17

            Wall Street Target Price

            8.15

            EPS Estimate Current Year

            -1.00

            EPS Estimate Next Year

            -0.99

            EPS Estimate Current Quarter

            -0.295

            EPS Estimate Next Quarter

            -0.2725

            Most Recent Quarter

            -

            Profitability

            Revenue TTM

            0

            Gross Profit TTM

            -190,240,000

            EBITDA

            -239,986,000

            Profit Margin

            0.00%

            Return On Assets TTM

            -28.92%

            Return On Equity TTM

            -59.60%

            Revenue Per Share TTM

            0

            Qtly Revenue Growth YOY

            -100.00%

            Diluted Eps TTM

            -1.17

            Qtly Earnings Growth YOY

            0.00%

            Valuation

            Trailing PE

            0.00

            Forward PE

            0

            Price Sales TTM

            11631.142

            Price Book MRQ

            0.6413

            Enterprise Value Revenue

            3859

            Enterprise Value EBITDA

            -1

            Peers analysis

            • CSL Limited
              CMXHFCSL Limited

              163.07

              6.57%
            • CSL Ltd
              CSLLYCSL Ltd

              78.89

              2.37%
            • Regeneron Pharmaceuticals Inc
              REGNRegeneron Pharmaceuticals Inc

              535.10

              1.98%
            • Vertex Pharmaceuticals Inc
              VRTXVertex Pharmaceuticals Inc

              453.00

              1.71%
            • Be
              ONCBeiGene, Ltd.

              244.79

              1.07%
            • argenx SE
              ARGNFargenx SE

              547.18

              -3.87%
            • UCB SA
              UCBJFUCB SA

              199.89

              -1.02%
            • argenx NV ADR
              ARGXargenx NV ADR

              547.00

              -0.73%
            • UCB SA ADR
              UCBJYUCB SA ADR

              98.75

              -0.59%
            • Alnylam Pharmaceuticals Inc
              ALNYAlnylam Pharmaceuticals Inc

              326.00

              -0.02%
            XM

            Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

            Trade with a Trusted, Award-Winning Broker.

            Trading involves risk. The value of investments may go up or down. Trade responsibly.

            FAQs

            What is Allogene Therapeutics stock price today?

            What is Allogene Therapeutics stock ticker?

            Is ALLO stock price going up?

            What is the analyst recommendation for ALLO?

            What is ALLO market cap?

            Does ALLO release financial reports?

            When is ALLO next earnings date?

            What were ALLO Earnings for the last quarter?

            What was ALLO Revenue for the last quarter?

            What was ALLO Net Income for the last quarter?

            Does ALLO pay dividends?

            How many employees does ALLO have?

            What is ALLO EBITDA?

            How to buy ALLO stocks?

            Should I invest in ALLO stock?